Recursion Pharmaceuticals(RXRX.US)

Event Tracking

Jan7

Recursion Pharmaceuticals Director Sold Shares

22:05

Dec31

Cathie Wood's ARK Investment Buys Recursion Pharmaceuticals Shares

05:02

Dec29

Recursion Pharmaceuticals Inc.'s Chief R&D Commercial Officer Sells Shares

22:25

Dec19

Recursion Pharmaceuticals CEO Plans to Sell 40,000 Shares

14:57

Dec17

JPMorgan upgrades Recursion Pharmaceuticals rating

14:02

Dec9

Recursion Pharmaceuticals Shares Show Initial Rebound, Undervalued and Advised for Exploration of Investment Opportunities

06:08

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 5.175 M, Net Income -162.25 M, EPS -0.3629

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.22 M, Net Income -171.9 M, EPS -0.4118

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.75 M, Net Income -202.49 M, EPS -0.5027

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change